Paracetamol — Drug Intelligence | 107 EU Trials

Filter these 107 trials by condition, phase, country and more.

Open in Search →

107 Registered trials

39 Recruiting

49 Completed trials

74 Sponsors

23 Countries

Phase III

Phase II

Phase IV

Phase III: 27 Phase II/III: 6 Phase II: 36 Phase I/II: 7 Phase III/IV: 3 Phase IV: 21 Phase I: 2 Phase I (Other): 1 Phase I (FiH): 4

Oversight events:

3 serious breaches 31 temporary halts 2 urgent safety measures 3 unexpected events 3 corrective measures across 15 trials

View oversight register →

Indications tested

Multiple sclerosis 5 Relapsing-remitting multiple sclerosis 3 Multiple sclerosis relapse 2 Relapsing multiple sclerosis 2 Diffuse large B-cell lymphoma recurrent 2 Follicular lymphoma 1 Metastatic malignant melanoma 1 Myasthenia gravis 1 Primary progressive multiple sclerosis 1 Amyotrophic lateral sclerosis 1 Coronary artery disease 1 Endometriosis 1

Sponsors using this IMP

F. Hoffmann-La Roche AG 6 Regeneron Pharmaceuticals Inc. 5 Centre Hospitalier Universitaire Amiens Picardie 3 Centre Hospitalier Universitaire De Nantes 3 Aarhus Universitet 2 Allogene Therapeutics Inc. 2 Assistance Publique Hopitaux De Paris 2 Celltrion Inc. 2 Centre hospitalier universitaire de Liege 2 Charite Universitaetsmedizin Berlin KöR 2 Emn Trial Office S.r.l. Impresa Sociale 2 European Myeloma Network B.V. 2

All trials

107 total

A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polys… Not authorised

2022-500228-31-00 Phase II/III 1 country Paradigm Biopharmaceuticals (USA) Inc.
Randomized, multiCentre, dOuble-blind, double-duMmy, parallel-group clinical study on efficacy and safety of iBuprofen/N-acetylcysteine fixe… Not authorised

2023-505809-17-00 Phase III 1 country E Pharma Trento S.p.A.
Medical therapy after shock wave lithotripsy Not authorised

2024-510792-38-00 Phase III 1 country Region Midtjylland
Medical therapy after shock wave lithotripsy Not authorised

2024-510792-38-01 Phase III 1 country Region Midtjylland
Short title: TOTT: Tailoring Obesity Treatment Trial Not authorised

2024-510802-10-00 Phase II/III 1 country Esbjerg Sygehus
A phase 2 study to research the safety and efficacy of datopotamab deruxtecan for non-squamous non-small cell lung cancer patients with acti… Not authorised

2024-512369-14-00 Phase II 2 countries Medica Scientia Innovation Research S.L.
SYMBOL CLINICAL : Treatment of severe ocular chemical burns by subconjunctival injection of allogeneic mesenchymal stem cells: a multicentre… Pending

2023-509713-37-00 Phase II 1 country Hopital Fondation Adolphe De Rothschild
ESP-BACK : Erector Spinae Plane Block for acute low back pain Pending

2024-511595-32-00 Phase IV 1 country Centre Hospitalier Universitaire De Montpellier
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of PPV-06 Active Immunotherapy… Pending

2024-514388-24-00 Phase II 5 countries Peptinov
Pilot study of the pharmacokinetic profile of subcutaneous versus intravenous paracetamol in palliative patients Pending

2024-518795-31-00 Phase II/III 1 country Centre Hospitalier Universitaire De Caen Normandie
A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy with Standard-of-Care Combination Regimens … Pending

2024-519504-27-00 Phase III 10 countries Regeneron Pharmaceuticals Inc.
Echo-guided scalp blocks and incidence of postoperative pain in scheduled supratentorial intracranial surgery. Pending

2024-520320-28-00 Phase III/IV 1 country Centre Hospitalier Universitaire De Bordeaux
Exploring the Psychoactive Effects of Paracetamol: A Randomized Controlled Trial. Pending

2025-522753-19-02 Phase IV 1 country Oslo Metropolitan University
A Trial to Study if REGN17372 in Combination with Linvoseltamab is Tolerable for Adult Participants with Relapsed/Refractory Multiple Myelom… Pending

2025-522776-93-00 Phase I 1 country Regeneron Pharmaceuticals Inc.
Evaluation of a New Pain Management Regime for Oocyte Pick-Up During Fertility Treatment Pending

2025-523018-10-00 Phase III/IV 1 country UZ Brussel
A Study Comparing the Efficacy and Tolerability of a Combination of Diclofenac and Thiocolchicoside Versus Diclofenac Monotherapy in Patient… Pending

2025-523153-33-00 Phase III 2 countries Verisfield Single Member S.A.
Rituximab as therapy for autoantibody mediated fibromyalgia (RAFT) - proof of concept Pending

2025-523465-21-00 Phase III 1 country Region Stockholm – SLSO
PHASE IB/II STUDY TO EVALUATE SAFETY AND PRELIMINARY EFFICACY OF ZANIDATAMAB IN COMBINATION WITH TUCATINIB AND CHEMOTHERAPY (CAPECITABINE OR… Pending

2025-524613-89-00 Phase I/II 1 country Medica Scientia Innovation Research S.L.
A Study Comparing the Efficacy and Tolerability of a Triple Combination of Diclofenac, Orphenadrine and Paracetamol Versus Diclofenac Monoth… Recruiting

2025-521578-32-00 Phase III 1 country Verisfield Single Member S.A.
Impact of prescribing nonsteroidal anti-inflammatory drugs in pleurodesis surgery after pneumothorax: a prospective randomized controlled do… Recruiting

2024-511226-32-00 Phase IV 1 country Centre Hospitalier Universitaire Amiens Picardie
A multi-center, open-label, phase 2 study of Elranatamab in patients with high-risk smoldering multiple myeloma Recruiting

2023-505775-70-00 Phase II 6 countries Emn Trial Office S.r.l. Impresa Sociale; European Myeloma Network B.V.
Evaluation of postoperative recovery when combining intravenous lidocaine with ropivacaine infiltration in laparoscopic colorectal oncologic… Recruiting

2025-523207-29-00 Phase IV 1 country Centre Hospitalier Universitaire Amiens Picardie
Multi-Center, Open Label Gene Therapy Study of RP-A501 in Male Patients with Danon Disease Recruiting

2023-506480-34-00 Phase II 2 countries Rocket Pharmaceuticals Inc.
Intra-articular corticosteroid injection vs arthrocentesis in the management of clinical arthritis of the temporomandibular joint: a randomi… Recruiting

2023-509114-11-00 Phase IV 1 country Vaestra Goetalandsregionen

Showing 1–24 of 107 trials

← All drugs A–Z